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Ozone, a major constituent of photochemi-
cal air pollution or smog, is a strong oxidiz-
ing agent and is potentially toxic. Nearly
113 million people live in U.S. counties
with ozone levels above the National
Ambient Air Quality (NAAQ) standards of
daily exposure limit (0.08 ppm for 8 hours)
(1). Ozone has very low water solubility and
thus cannot effectively penetrate the very
thick epithelial lining fluid (ELF) in the
upper airways. However, in the lower air-
ways, including bronchiolar and alveolar
regions, the ELF is not as thick, thereby
allowing ozone to penetrate and react with
various constituents in the fluid and the
underlying cells. Thus, ozone toxicity is
observed mostly in the lower airways. Ozone
reacts with unsaturated C=C bonds, amino
acids, and other chemical structures, and
ozone exposure can lead to edema, inflam-
mation, and epithelial cell damage, con-
tributing to lung injury and pulmonary
surfactant derangement (2). The compo-
nents of pulmonary surfactant (a lipoprotein
complex) essential for normal lung function
are likely to be vulnerable to reaction with
inhaled ozone. In fact, both biochemical (3)
and morphologic alterations (4,5) in surfac-
tant have been observed following ozone
exposure. Moreover, ozone-exposed surfac-
tant protein A (SP-A) has shown a reduced
ability to bind carbohydrates and self-aggre-
gate (6) and to inhibit phosphatidylcholine
secretion by type II cells (7).
Human surfactant protein A consists of
two functional genes, SP-A1 and SP-A2, and
one pseudogene. More than 30 alleles have
been characterized (8), and 10 of them
appear with > 1% frequency in the general
population (8,9). These alleles are classiﬁed
based on nucleotide differences within the
coding region, and produce 10 amino acid
differences among SP-A1 and SP-A2 alleles.
These are located in the signal peptide
region, the collagen-like domain, and the
carbohydrate recognition domain (CRD)
(9). Given that there is an order of prefer-
ence (Cys>Trp=Met>Tyr>His) for ozone to
react with free amino acid (10) and that cer-
tain amino acids in which the SP-A alleles
differ may be more susceptible to oxidation,
it is possible that certain SP-A alleles are
more susceptible to oxidation than others.
Human SP-A, in addition to surfactant
related functions, plays a role in innate host
defense and the regulation of inﬂammatory
processes in the lung (11–13). Human SP-A
from bronchoalveolar lavage (BAL) can
stimulate cytokine production in the
macrophage-like cell line, THP-1, and this
effect is inhibited by the surfactant lipids
(14,15). SP-A variants expressed in vitro
using the baculovirus-mediated expression
system stimulate TNF-α production in
THP-1 cells. However, differences were
observed between SP-As derived from single
and both gene products, and between SP-A1
and SP-A2 variants (16). 
In the present study, we expressed SP-A
variants using mammalian Chinese hamster
ovary (CHO)-K1 cells and examined their
ability to stimulate cytokine production
(TNF-α and IL-8) by THP-1 cells before
and after exposure to ozone. We observed
biochemical and functional differences
among the variants both before and after
ozone exposure.
Materials and Methods
Cell lines and cell culture conditions. We used
the mammalian CHO-K1 cell line (Cat
#CCL 61; American Type Culture Collection,
Manassas, VA) for expression of human
SP-A variants. The cells were cultured in
Glasgow’s modified Eagle’s medium
(GMEM) (Invitrogen, Carlsbad, CA) plus
10% fetal bovine serum (FBS) at 37°C in an
atmosphere of 5% CO2. The stably trans-
fected cell lines from the pEE14-hSP-A
transfection were grown in glutamine-free
GMEM medium plus 25 µM methionine
sulfoximine (MSX); and the stably trans-
fected cell lines from the pCI-neo-hSP-A
transfection were maintained in GMEM
medium plus 300 mg/L of the antibiotic
G418. For the double-gene stably trans-
fected cell lines from the pEE14-hSP-A and
pCI-neo-hSP-A transfection, cells were cul-
tured in glutamine-free GMEM medium
plus 300 mg/L of G418. The THP-1 cell
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Articles
Ozone exposure can cause inﬂammation and impaired lung function. Human surfactant protein
A (SP-A) may play a role in inﬂammation by modulating cytokine production by macrophages.
SP-A is encoded by two genes, SP-A1 and SP-A2, and several allelic variants have been character-
ized for each gene. These allelic variants differ among themselves in amino acids that may exhibit
differential sensitivity to ozone-induced oxidation and this may produce functional differences.
We studied the effects of SP-A variants before and after ozone exposure on the production of
tumor necrosis factor (TNF)-α and interleukin (IL)-8. These are important proinflammatory
cytokines and are expressed by the macrophage-like THP-1 cells. Eight variants were expressed in
vitro, characterized by gel electrophoresis, and studied. These included six single-gene SP-A alleles
and two SP-A variants derived from both genes. Variants were exposed to ozone at 1 ppm for 4 hr
at 37°C, and we compared their ability to stimulate cytokine (TNF-α and IL-8) production by
THP-1 cells to air-exposed and unexposed SP-A variants. We found that a) SP-A2 variants (1A,
1A0, 1A1) stimulate significantly more TNF-α and IL-8 production than SP-A1 variants (6A,
6A2, 6A4); b) coexpressed SP-A variants (1A0/6A2, 1A1/6A4) have significantly higher activity
than single gene products; c) after ozone exposure, all SP-A variants showed a decreased ability to
stimulate TNF-α and IL-8 production, and the level of the decrease varied among SP-A variants
(26–48%); and d) human SP-A from patients with alveolar proteinosis exhibited a minimal
decrease (18% and 12%, respectively) in its ability to stimulate TNF-α and IL-8 after in vitro
ozone exposure. We conclude that biochemical and functional differences exist among SP-A vari-
ants, that ozone exposure modulates the ability of SP-A variants to stimulate cytokines by THP-1
cells, and that SP-As from bronchoalveolar lavage (BAL) fluid of certain alveolar proteinosis
patients may be oxidized in vivo. Key words: allele, cytokine, IL-8, ozone, surfactant protein A
(SP-A), THP-1 cell, TNF-α. Environ Health Perspect 110:79–84 (2002). [Online 18 December
2001] http://ehpnet1.niehs.nih.gov/docs/2002/110p79-84wang/abstract.htmlculture and differentiation were performed
as described previously (16) using RPMI
1640 culture medium with 0.05 mM β-mer-
captoethanol and differentiating the cells for
72 hr in the presence of 10–8 M vitamin D3.
Constructs of SP-A alleles. We cloned
and expressed SP-A alleles that differ in
amino acids that may exhibit differential sus-
ceptibility to ozone oxidation, and this
process may produce functional differences.
The rationale for studying these alleles is
based on the functional importance of SP-A
and the potential for functional differences
among these alleles caused by their amino
acid differences. Differences in the ability of
these alleles to stimulate proinflammatory
cytokine production may explain partly the
individual susceptibility to (or protection
from) inflammation before and/or after
ozone exposure.
For the cloning and expression of SP-A
alleles, we used two expression vectors, plas-
mids pEE14 (LONZA, Berkshire, UK) and
pCI-neo (Promega, Madison, WI). pEE14
and pCI-neo contain different selection mark-
ers, neomycin phosphotransferase and gluta-
mine synthetase, respectively. The use of two
different selection markers facilitated selection
efforts when screening for the transgenic cell
lines that expressed both the SP-A1 and
SP-A2 genes. For the pEE14-hSP-A construct,
a 1.3 kb cDNA segment from an SP-A2 allele
(e.g., 1A, 1A0, 1A1) was cloned into the SmaI
restriction site of the pEE14 vector. This 1.3
kb insert cDNA includes 0.74 kb coding
region, about 0.1 kb of 5´UTR, and 0.5 kb of
3´UTR. Expression of the SP-A cDNA is
controlled by the human cytomegalovirus
(CMV) immediate-early enhancer/promoter
region. Stable transgenic cells are selected in
glutamine-deﬁcient medium (17).
For the pCI-neo-hSP-A construct, a 1.3
kb cDNA segment from an SP-A1 allele (e.g.
6A2, 6A4 ) was inserted into Xho I and Acc I
of the pCI-neo vector. This 1.3 kb insert
cDNA includes 0.74 kb of coding region,
about 0.1 kb 5´UTR, and 0.5 kb 3´UTR. A
0.9 kb cDNA segment of the SP-A1 allele
6A was cloned into Eco RI site of the
pCI-neo vector. The 6A insert, in addition
to the coding region, includes about 0.1 kb
5´UTR and 0.1 kb 3´UTR. The expression
of cDNA in the PCI-neo vector is also dri-
ven by the human CMV immediate-early
enhancer/promoter region. The intron
sequence between the promoter region and
the insert DNA in the vector can increase
the expression level (18). Stably transfected
cells were selected for neomycin phospho-
transferase activity (neomycin resistance).
Recombinant constructs were made accord-
ing to standard methods (19). 
CHO cell transfection and selection of
stably transfected cell lines. CHO-K1 cells
were cultured in GMEM. Adherent CHO
K1 cells were transfected with pCI-neo-hSP-
A, pEE14-hSP-A, pCI-neo, pEE14, or 
mock-transfected with LipofectAMINE
(GIBCO/BRL) according to the manufac-
turer’s instructions. Approximately, 5 × 106
cells in one 60-mm plate were transfected
with 8 µg of plasmid DNA in GMEM in
the presence of 33 µL of LipofectAMINE
and in the absence of serum and antibiotics.
Incubations were done for periods of 6–22
hr. The transfected cells were then incubated
in GMEM containing 10% FBS for 48 hr.
The cells were split at 1:8 and incubated for
48 hr in glutamine-free GMEM containing
10% dialyzed FBS supplemented with 25
µM MSX. CHO cells from pCI-neo-hSP-A
and pCI-neo transfection were cultured in
GMEM plus 10% FBS, and 600 mg/L of
G418. After 2–3 weeks, we isolated colonies
of vigorously proliferating cells from trans-
fected cultures using a cloning cylinder.
After the cells reached confluence, fresh
culture medium was applied. We then
screened primary cell clones using a semi-
quantitative solid-phase immunoassay and
by immunoblotting with rabbit anti-SP-A
antibody (16). Selected cell lines of transfor-
mants were further ampliﬁed after exposure to
a higher concentration of MSX (60 µM). For
double transfections with SP-A1 and SP-A2,
we selected and screened clones as described
above, except that the selection medium was
glutamine-free and contained the selection
factor 600 mg/L G418. Three SP-A1 alleles
(i.e., 6A, 6A2, 6A4) were cloned into expres-
sion plasmid pCI-neo, three SP-A2 alleles
(i.e., 1A, 1A0, 1A1) were cloned into expres-
sion plasmid pEE14, and two co-expression
combinations, 1A0/6A2, 1A1/6A4 were pro-
duced by cotransfection of both plasmids. 
After selection, more than 40 stably trans-
fected cell clones were obtained. We veriﬁed
SP-A expression in single gene transfected
clones using Western blotting. To identify the
expression of both genes of SP-A1 and SP-A2,
we isolated mRNA from putative clones that
can grow in the presence of the antibiotic
G418 and in glutamine-deficient medium.
We used SP-A1 and SP-A2 speciﬁc primers
for gene-speciﬁc RT-PCR to verify expression
of both genes, and we used PCR-cRFLP
genotyping (8) to conﬁrm each cloned allele.
Clones that expressed both SP-A1 and SP-A2
genes were propagated. Expression of SP-A1
and SP-A2 genes was further veriﬁed by two-
dimensional gel electrophoresis and Western
blot analysis. About 80% of the clones trans-
fected with pEE14-hSP-A expressed SP-A,
about 30–50% of the clones transfected with
pCI-neo-hSP-A expressed SP-A, and only
10–30% of clones transfected with both
SP-A1 and SP-A2 constructs expressed both
SP-A1 and SP-A2 proteins.
We detected SP-A protein in the medium
of the transfected cells, but no SP-A protein
in the medium of mock transfected cells (data
not shown), indicating that CHO-K1 cells
express only transfected human SP-A gene(s)
rather than their own SP-A gene.
Preparation of SP-A variants and native
human SP-A. We recovered and purified
SP-A from the culture medium using man-
nose-affinity chromatography according to
the method of Fornstedt and Porath (20).
Briefly, we harvested about 200 mL of
serum-free culture medium (2 × 107
cells/plate/10 mL) from a 5-day culture. We
removed CHO cells and cell fragments from
the culture medium by centrifugation at
1,000 × g for 10 min at 4°C. The super-
natant was then transferred to new tubes and
passed through a sepharose-6B column fol-
lowed by a polymyxin-B-agarose column (all
columns from Sigma, St. Louis, MO). The
solution containing SP-A was adjusted to 10
mM Ca2+ with 1 M CaCl2, and was passed
through a mannose-sepharose 6B column
(40 mL) at about 60 mL/hr. The column
was then washed with 200 mL of 5 mM
Tris, 1 mM CaCl2, pH 7.5. SP-A was eluted
with an elution buffer containing 5 mM
Tris, 2 mM EDTA, pH 7.5 and collected in
2 mL fractions. We puriﬁed SP-A by repeat-
ing the mannose affinity procedure and gel
filtration with a Superose 6 column
(Amersham Pharmacia Biotech, Piscataway,
NJ). SP-A was dialyzed as described (16).
The native human SP-A was purified from
BAL ﬂuid obtained from alveolar proteinosis
patients by a method previously described
(16). SP-A was concentrated using Amicon
Centriprep-10 concentrators (Amicon,
Beverly, MD). All procedures were per-
formed at 4°C or on ice. We determined
protein concentration using the Micro-BCA
method of Smith et al. (21) (Pierce,
Rockford, IL) with RNase A as standard.
SP-A was aliquoted and stored at –70°C.
Gel electrophoresis, silver staining, and
Western blotting of SP-A were done as
described previously (16).
As a part of the SP-A purification, we
removed lipopolysaccharide (LPS) from
SP-A preparations by incubating the puriﬁed
SP-A with polymyxin-B-agarose (1 mL
agarose beads/mg SP-A) according to manu-
facturer’s instructions (Sigma, St. Louis,
MO). We assessed the LPS content of SP-A
preparations using the QCL-1000 assay, a
test employing Limulus Amebocyte Lysate
(BioWhitaker, Walkersville, MD). Purified
preparations of SP-A contained less than 0.1
pg of LPS/µg of SP-A.
Exposure of SP-A to ozone. We exposed
SP-A proteins at a concentration of 1
mg/mL to ozone in 24-well tissue culture
plates as described previously (22). Each well
Articles • Wang et al.
80 VOLUME 110 | NUMBER 1 | January 2002 • Environmental Health Perspectivescontained 100 µL of solution, which was
about 0.5 mm deep. Plates were weighed
before and after each exposure to check for
changes in sample volumes. We conducted
ozone concentration and time course expo-
sures to determine optimal exposure condi-
tions. An ozone concentration of 1 ppm for
4 hr was optimal for protein oxidation, and
all of the following exposures were made
using these conditions. After exposure, pro-
teins were transferred to sterile microcen-
trifuge tubes and stored at –80°C until
further use. At least three independent
experiments were performed in this study.
Detection of protein oxidation. We
detected protein oxidation using the
OxyBlot oxidized protein detection kit
(Intergen, Purchase, NY) (22). Brieﬂy, after
ozone exposure, samples were derivatized
with 2,4-dinitrophenylhydrazine (DNPH).
DNPH-derivatized protein (200 ng) was
blotted onto nitrocellulose and immunode-
tection of oxidized proteins was done with
rabbit anti-DNPH and goat anti-rabbit IgG
(HRP-conjugated) antibodies. Blots were
exposed to XAR film following enhanced
chemiluminescent detection.
SP-A treatment of THP-1 cells and
ELISA assay for TNF-α and IL-8. After dif-
ferentiation with 10–8 M vitamin D3 for 72
hr, THP-1 cells were washed with culture
medium and exposed to SP-A (50 µg/mL).
As positive controls, we used human SP-A
from BAL fluid (50 µg/mL) and LPS (0.1
ng/mL). Incubations were performed with 2
× 106 cells/mL in 24-well culture plates for
periods ranging from 0 to 12 hr or using a
4-hr time point. Fetal calf serum (10%) was
present in all incubations.
We performed TNF-α and IL-8 ELISA
assays as recommended by the manufacturer
(PerSeptive Diagnostics, Cambridge, MA).
We analyzed samples with 100 µL/well in a
96-well plate. And we obtained a reference
curve by plotting the TNF-α or IL-8 con-
centration of several dilutions of standard
protein versus absorbance.
Statistical methods. TNF-α and IL-8 data
obtained from three independent experiments
were expressed as the mean ± SE. Levels of
TNF-α and IL-8 induced by various SP-As
were compared and analyzed by multiple
comparison ANOVA test. Differences were
considered signiﬁcant when the p value was
< 0.05. 
Results
Characteristics of SP-A variants from CHO-
K1 cells. Six SP-A alleles 6A, 6A2, 6A4, 1A,
1A0, 1A1, and the two combinations
1A0/6A2 and 1A1/6A4 were successfully
expressed as described above. Expressed
SP-A protein was secreted into the culture
medium, suggesting that the signal peptide
of human SP-A is functional in CHO-K1
cells, and the secreted SP-A was puriﬁed. We
used serum-free GMEM medium for SP-A
expression because it was difficult to purify
SP-A from serum-containing medium. After
purification according to the method
described in “Materials and Methods,” SP-A
purity was assessed at 99% (Figure 1). The
SP-A pattern shown in Figure 1 indicates
that the in vitro expressed SP-A from mam-
malian CHO-K1 cells is similar to SP-A
from human BAL ﬂuid. This indicates that
similar post-translational modifications
occur in the in vitro expressed SP-A protein
and the native human SP-A protein. These
post-translational modifications may be
important for some SP-A functions. 
Oxidation of SP-A after ozone exposure.
We studied two representative SP-A alle-
les—SP-A1 allele 6A and SP-A2 allele 1A—
in ozone time-course and dose–response
experiments, to determine the optimal ozone
exposure time and concentration. Alleles 1A
and 6A were exposed to ozone at 1 ppm for
30 min, 1 hr, 2 hr, 4 hr, and 12 hr. The
results showed that neither 1A nor 6A is oxi-
dized before ozone exposure, but both are
oxidized after ozone exposure (Figure 2A).
The degree of SP-A oxidation increased as
the length of exposure time (from 30 min to
4 hr) increased. When the exposure was pro-
longed to 12 hr, we saw no marked differ-
ence between the 4-hr exposure and the
12-hr exposure. For the ozone concentration
course experiment, we exposed SP-A alleles
1A and 6A for 4 hr at the following concen-
trations of ozone: 0.1 ppm, 0.5 ppm, 1 ppm,
and 2 ppm. Figure 2B shows that the signal
for oxidized SP-A increased from 0.1 ppm to
1 ppm, but no marked difference was
detected between 1 ppm and 2 ppm. 
Subsequently, we determined the func-
tional changes of SP-A following ozone
exposure. We tested ozone-exposed SP-A
alleles 1A and 6A from the ozone time-
course and ozone dose–response experiments
for their ability to stimulate TNF-α produc-
tion by THP-1 cells (Figure 3). Before ozone
treatment, the SP-A2 allele 1A and the
SP-A1 allele 6A stimulate TNF-α produc-
tion (814 ± 47 pg/mL and 452 ± 35 pg/mL,
respectively, vs. positive control hSP-A 437
± 21pg/mL) by THP-1 cells. After ozone
exposure, the ability of SP-A alleles 1A and
6A to stimulate TNF-α production
decreased. When SP-A was exposed to ozone
from 30 min to 4 hr and then used to stimu-
late THP-1 cells, the degree of stimulation
of the TNF-α level consistently decreased as
the ozone exposure time of the SP-A
increased. The TNF-α levels resulting from
treatment with 1A and 6A at 4 hr are 66%
and 60%, respectively, of the levels observed
before ozone treatment. However, no
marked difference of TNF-α levels exists
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Figure 1. Gel electrophoresis of SP-A from in vitro-expressed and BAL-derived
SP-A. IEF, isoelectric focusing. (A) and (B) depict CHO-K1-expressed SP-As
and (C) depicts SP-A from BAL of an alveolar proteinosis patient. Puriﬁed SP-A
was separated by two-dimensional gel electrophoresis. Gels were subjected
to silver staining (A,C) and Western blotting with an antiserum to human SP-A
(B). The numbers on left indicate molecular mass. 
Figure 2. SP-A oxidation as a function of time and ozone concentration. FA, ﬁl-
tered air. Two in vitro-expressed SP-A variants, 1A and 6A, from SP-A2 and
SP-A1, respectively, were exposed to ozone (1 ppm) at different times (A) and at
different ozone concentrations for 4 hr (B). Each sample (200 ng) was blotted onto
a membrane and the oxidized proteins were detected using the OxyBlot method.
The optimal time and ozone concentration for exposure was 4 hr and 1.0 ppm. 
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A Bbetween the 4 hr exposure time point and
the 12 hr time point, suggesting that SP-A
oxidation after a 4 hr exposure at 1 ppm has
reached a plateau with regard to the end
point studied here.
We next assessed the effect of ozone con-
centration on SP-A oxidation and function.
We exposed SP-A alleles 1A and 6A to ozone
at different concentrations including 0.1 ppm,
0.5 ppm, 1 ppm, and 2 ppm for 4 hr. Figure 4
shows that after exposure to 1 ppm ozone, 1A
and 6A stimulate TNF-α by THP-1 cells at
signiﬁcantly lower levels than SP-A exposed to
0.1 ppm or 0.5 ppm (p < 0.05). No signiﬁcant
difference of TNF-α levels was found when
exposure was increased from 1 ppm to 2 ppm. 
Given SP-A oxidation and functional
changes, we concluded that exposure to 1
ppm ozone for 4 hr is the optimal condition,
so we used this standard for subsequent
experiments.
Comparison of the effects of unexposed
and ozone-exposed SP-A on the stimulation
of cytokines by THP-1 cells as a function of
time. Vitamin D3-differentiated THP-1 cells
were stimulated for different time periods
(1–12 hr) with either normal (unexposed) or
ozone-exposed SP-A1 allele 6A and SP-A2
allele 1A (50 µg/mL). Figure 5 shows that
after 1 hr of incubation with SP-A, TNF-α
was detected in the culture medium of
THP-1 cells at levels above background. The
content of TNF-α in the medium increased
dramatically from 1 to 4 hr, and reached a
peak at 4 hr. The content of TNF-α subse-
quently decreased, although it was still above
background at 12 hr. The levels of TNF-α
stimulation by unexposed SP-A 6A and 1A
were significantly higher than those from
ozone-exposed SP-A 6A and 1A. However,
the time course of TNF-α production was
identical for the unexposed and ozone-
exposed variants. 
Similarly, we analyzed IL-8 production by
THP-1 cells in response to SP-A in a time
course experiment. The results are shown in
Figure 6. IL-8 was detected in the medium
after a 2-hr incubation. The level of IL-8 dra-
matically increased from 2 to 4 hr, and contin-
ued to increase from 4 to 12 hr. At the 4-hr
time point the level of IL-8 reached about
80% of the highest level measured (12-hr time
point). Therefore, we considered a 4-hr time
point optimal for measuring both TNF-α and
IL-8 to compare the effects of different SP-A
variants in subsequent experiments.
Comparison of ozone-exposed, air-
exposed, and unexposed SP-A variants on
the stimulation of TNF-α production. We
tested eight SP-A variants for their ability to
stimulate TNF-α production. Of these,
three were SP-A1 alleles (6A, 6A2, 6A4),
three were SP-A2 alleles (1A, 1A0, 1A1), and
two were coexpressed SP-As (1A0/6A2,
1A1/6A4). We performed three independent
experiments involving treatment of THP-1
cells with SP-A at a concentration of 50
µg/mL for 4 hr. The content of TNF-α in
THP-1 cell culture supernatants after stimu-
lation with SP-A is summarized in Table 1.
All six SP-A alleles and the two coexpressed
SP-As stimulate TNF-α production by
THP-1 cells. The SP-A2 variants 1A, 1A0,
1A1 stimulate TNF-α production signifi-
cantly more than SP-A1 variants 6A, 6A2,
6A4 (p < 0.01). Both coexpressed SP-A vari-
ants have significantly higher activity than
SP-A1 variants 6A, 6A2, 6A4 (p < 0.01), and
they also appear to have higher activity than
SP-A2 variants 1A, 1A0, 1A1. The ability of
air-exposed SP-A variants to stimulate
TNF-α production was similar to that of
unexposed SP-A variants. As positive con-
trols, we used human SP-A from BAL ﬂuid
(50 µg/mL) and LPS (0.1 ng/mL), and both
stimulated TNF-α production to levels of 437
± 21 pg TNF-α/mL and 384 ± 23 pg TNF-
α/mL, respectively. In untreated negative con-
trols, the level of TNF-α in the medium was
26 ± 7 pg TNF-α/mL (Table 1).
After ozone exposure, all the SP-A vari-
ants were signiﬁcantly inhibited in their abil-
ity (range 33–48%) to stimulate TNF-α
production compared with air-exposed SP-A
variants, but the percent change (O3/air) for
SP-A variants 6A4 and 1A1/6A4 was larger
than that of other variants. For 6A4 there
was a 55% change versus 64% (6A) or 67%
(6A2) and for 1A1/6A4, 52% versus 61% for
1A0/6A2. These observations indicate that
the oxidation of SP-A decreases its ability to
stimulate TNF-α production, and that dif-
ferences may occur among SP-A variants.
Human SP-A from BAL of an alveolar pro-
teinosis patient was used as a positive con-
trol. The ability of this ozone-exposed SP-A
to stimulate TNF-α production was reduced
by only 18% compared to that of the air-
exposed SP-A. 
Comparison of ozone-exposed, air-
exposed, and unexposed SP-A variants on
the stimulation of IL-8 production. We fur-
ther analyzed cytokine IL-8 content in the
medium of THP-1 cells after stimulation
with SP-A variants for 4 hr. The results are
summarized in Table 2. All of the SP-A vari-
ants 6A, 6A2, 6A4, 1A, 1A0, 1A1, 1A0/6A2,
and 1A1/6A4 stimulate IL-8 production by
THP-1 cells, and the activity of air-exposed
SP-A variants was similar to that of unex-
posed SP-A variants. The levels of IL-8 for
all treatments are substantially higher than
that of the negative control. The SP-A2 vari-
ants 1A, 1A0, 1A1 have significantly higher
activity than SP-A1 variants 6A, 6A2, 6A4.
Coexpressed SP-As 1A0/6A2, 1A1/6A4 con-
sisting of both gene products have signifi-
cantly higher activity than SP-A1 variants
6A, 6A2, 6A4 (p < 0.01) and SP-A2 variants
1A, 1A0, 1A1 (p < 0.05). 
After ozone exposure, all of the SP-A
variants had a significantly reduced ability
(range 26–45%) to stimulate IL-8 produc-
tion compared to that with air-exposed SP-A
variants (p < 0.01). The percent change
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Figure 3. Time course of the effect of ozone-
exposed SP-A on TNF-α production. Data were
obtained from three independent experiments. 
**p < 0.01; there is a significant difference between
ozone-exposed SP-A and untreated SP-A (zero hour
point). 
Figure 4. Ozone dose response study of the ability
of SP-A to stimulate TNF-α production. Data were
obtained from three independent experiments. 
**p < 0.01; there is a significant difference between
ozone-exposed SP-A and untreated SP-A (zero ppm
ozone exposure).
Figure 5. Time course of TNF-α production by
THP-1 cells treated with SP-A before and after
ozone exposure. Data were obtained from three
independent experiments. 
**p < 0.01; there is a signiﬁcant difference between ozone-
exposed SP-A (1A or 6A) and untreated SP-A (1A or 6A).
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**(O3/air) for 6A4 and 1A1/6A4 variants
tended to be lower than that for other SP-A
variants (Table 2). The activity of the ozone-
exposed SP-A from BAL ﬂuid of the alveolar
proteinosis patient (described previously)
was only 13% lower than for the air-exposed
SP-A. 
Discussion 
Ozone, a strong oxidative agent, can impair
lung function and cause lung injury and
inflammation via oxidative reactions with
epithelial cells and surfactant components in
the lung and airways. A remarkably high
variability in response to ozone has been
observed (23–25), and genetic factors have
been implicated in this variability. Human
SP-A plays a role in inflammation by regu-
lating cytokine production by macrophages.
SP-A is encoded by two genes, SP-A1 and
SP-A2, and several allelic variants have been
characterized for each gene. These allelic
variants differ among themselves in amino
acids that may exhibit differential suscepti-
bility to ozone exposure and this may result
in functional differences. Differences in the
ability of these alleles to stimulate proinﬂam-
matory cytokine production may explain in
part the individual susceptibility to inflam-
mation before and/or after ozone exposure.
In this study, we investigated the hypotheses
that biochemical and functional differences
exist among SP-A variants and that ozone
affects the functional abilities of these pro-
tein variants. We observed differences in
function among SP-A1, SP-A2, and coex-
pressed SP-A variants, before and after ozone
exposure. All of the ozone-exposed SP-A
variants exhibited a decreased ability to stim-
ulate cytokine production, although the
degree of the decrease varied among SP-A
variants, with allele 6A4 and the coexpressed
1A1/6A4 showing the greatest decrease. This
variability may reflect differences among
individuals in their susceptibility to ozone,
and may be, in part, the basis for individual
variability in susceptibility to lung disease.
Native SP-A is expressed by several cell
types, including the type II alveolar epithelial
cells in the lung, and secreted into the lung
alveolar space (26). As the SP-A precursor is
processed to form mature SP-A, it undergoes
several post-translational modifications
including N-linked glycosylation, hydroxyla-
tion of proline residues, addition of sialic
acid to the oligosaccharide, and signal pep-
tide cleavage (26,27). These post-transla-
tional modifications may be involved in
some SP-A functions (28). Of interest, in
vitro expressed SP-As from the baculovirus-
mediated insect cell expression system,
which are deﬁcient in proline hydroxylation
and show incomplete N-linked glycosylation
(16,29), exhibit a lower activity in their abil-
ity to stimulate TNF-α production by
THP-1 cells than does SP-A expressed from
mammalian (CHO) cells, which undergoes
proline hydroxylation and more complete
processing of N-linked oligosaccharides. In
vitro expressed SP-As from CHO cells
appear to have post-translational modifica-
tions similar to those on native human SP-A,
so these SP-A preparations should have func-
tion(s) similar to those of native human
SP-A. Moreover, SP-A expressed from trans-
fected CHO cells is not oxidized (as SP-A
from alveolar proteinosis patients might be)
before ozone exposure, which is an essential
prerequisite for this study. The quality of
SP-A samples prepared from BAL fluid of
alveolar proteinosis patients (an enriched
source for SP-A) varied, with two out of
three tested being highly oxidized (22)
before ozone exposure.
The production of both TNF-α and
IL-8 by THP-1 cells was enhanced after
stimulation by SP-A, but the kinetics of the
changes and pattern proﬁles of each cytokine
differed, suggesting complex interactions.
TNF-α was detected in the medium after 1
hr of SP-A stimulation, and peaked at the
4-hr time point. IL-8 was detected in the
medium at 2 hr after stimulation with SP-A.
The content of IL-8 in the medium contin-
ued to increase from 2 hr to 12 hr. Although
the IL-8 production is likely to be induced
by both SP-A (15) and TNF-α (30), the rel-
ative contributions of SP-A and TNF-α to
the increase in IL-8 production are
unknown and will be the focus of further
investigation. The most likely reason why
this proteinosis-derived SP-A preparation
shows a very small change in its functional
capability after in vitro ozone exposure is
probably that it was already highly oxidized
before in vitro ozone exposure (22); hence,
the low percent change after ozone exposure.
Although all human SP-A variants
expressed in CHO cells stimulate TNF-α
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Table 1. TNF-α (pg/mL) production by THP-1 cells after a 4-hr stimulation by SP-Aa before or after its
exposure to ozone.b
SP-A variants Unexposed Exposed SP-A
or control SP-A + Air + Ozone (1 ppm) O3/air (%)
6A 479 ± 24 495 ± 21 321 ± 19** 64
6A2 387 ± 15 406 ± 26 274 ± 14** 67
6A4 456 ± 32 489 ± 28 267 ± 23** 55
1A 824 ± 41 794 ± 35 521 ± 24** 65
1A0 756 ± 33 801 ± 41 472 ± 38** 59
1A1 713 ± 49 782 ± 31 493 ± 23** 63
1A0/6A2 984 ± 54 951 ± 45 580 ± 33** 61
1A1/6A4 923 ± 43 907 ± 23 471 ± 23** 52
hSP-A 437 ± 21 395 ± 31 324 ± 19* 82
LPS (0.1 ng/mL) 384 ± 23
Untreated control 26 ± 7
aSP-A, 50 µg/mL. bOzone, 1 ppm for 4 hr at 37°C. *p < 0.05, **p < 0.01 ozone-exposed SP-A versus air-exposed SP-A. 
Table 2. IL-8 (pg/mL) production by THP-1 cells after a 4-hr stimulation by SP-Aa before or after its expo-
sure to ozone.b
SP-A variants Unexposed Exposed SP-A
or control  SP-A + Air + Ozone (1 ppm) O3/air (%)
6A 478 ± 39 461 ± 35 312 ± 32 ** 68
6A2 439 ± 45 428 ± 27 273 ± 24 ** 64
6A4 468 ± 38 435 ± 32 243 ± 38 ** 56
1A 564 ± 41 578 ± 43 433 ± 34 ** 74
1A0 621 ± 48 604 ± 41 419 ± 38 ** 69
1A1 603 ± 39 569 ± 34 375 ± 39 ** 65
1A0/6A2 728 ± 45 685 ± 32 418 ± 38 ** 61
1A1/6A4 789 ± 19 768 ± 46 422 ± 32 ** 55
hSP-A 382 ± 41 369 ± 32 321 ± 27 87
LPS (0.1 ng/mL) 452 ± 39
Untreated control 69 ± 31
aSP-A, 50 µg/mL; bOzone, 1 ppm for 4 hrs at 37°C. **p < 0.01, ozone-exposed SP-A versus air-exposed SP-A.
Figure 6. Time course of IL-8 production by THP-1
cells treated with the SP-A before and after ozone
exposure. Data were obtained from three inde-
pendent experiments. 
**p < 0.01; there is a significant difference between
ozone-exposed SP-A (1A or 6A) and untreated SP-A (1A
or 6A).
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**production by THP-1 cells, as shown for
SP-A variants expressed by insect cells (16),
the activity is higher in SP-A variants
expressed by mammalian cells. The relative
changes observed among variants produced
either by mammalian or insect cells are simi-
lar. In both cases, SP-A2 alleles have higher
activity than SP-A1 alleles, and SP-As
derived from both genes have higher activity
than SP-As of single gene products. All of
the SP-A2 alleles differ from all of the SP-A1
alleles at four amino acids within the colla-
gen-like domain, and these differences may
affect SP-A structure and function. After
ozone exposure, all of the human SP-As had
decreased ability to stimulate cytokine pro-
duction by THP-1 cells, but some SP-A
variants showed a greater decrease than oth-
ers. In particular, allele 6A4 and coexpressed
1A1/6A4 showed a greater decrease than
other variants. Allele 6A4 has a tryptophan at
position 219, whereas all other alleles have
an arginine (9). Tryptophan is more suscep-
tible than arginine to oxidation by ozone
(10). Allele 1A1 has a lysine at position 223,
and the other alleles have a glutamine (9).
Although neither lysine nor glutamine is
sensitive to oxidation, these differences in
amino acids may have an indirect effect on
protein conformation, which in turn may
expose amino acids that are more sensitive to
ozone oxidation. In fact, oxidized SP-A has
been shown to exhibit changes in its molecu-
lar conformation and a decreased ability to
interact with alveolar macrophages (7).
Similarly, ozone-exposed human SP-A vari-
ants might undergo changes in their confor-
mation that may decrease their ability to
interact with THP-1 cells. It is not known
how SP-A exerts its activity on THP-1 cells,
although it is known that it can bind to C1q
receptor (31). Altered SP-A conformation
may lead to changes in such an interaction. 
In summary, our results indicate that a)
single SP-A gene variants and coexpressed
(both SP-A gene products) variants can be
successfully expressed and puriﬁed from sta-
bly transfected mammalian cell lines; b) the
in vitro expressed variants can stimulate
cytokine production (TNF-α, IL-8) in a
time- and dose-dependent manner; c) differ-
ences exist among SP-A variants in the degree
of stimulation of cytokine production; d) the
time- and dose-dependent pattern of stimula-
tion is maintained after ozone exposure of
the SP-A variants, but the degree of stimula-
tion is decreased; and e) the percent change
in the degree of stimulation of cytokine pro-
duction by SP-A variants before and after
ozone exposure varies among certain variants.
It is possible that the SP-A of certain individ-
uals is more susceptible to ozone oxidation
than others, and this may help explain indi-
vidual differences in susceptibility or resis-
tance to ozone-related pulmonary disease.
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